FDA 483 - RLC Labs Inc. - September 15, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Specialty Process Labs LLC in Phoenix, AZ, an Active Pharmaceutical Ingredient (API) manufacturer, received a Form 483 citing three significant observations. The firm failed to ensure the timely destruction of recalled drug products, lacked documented procedures for laboratory data control and sample chain-of-custody, and did not have an adequate ongoing stability testing program for its intermediates and APIs. These issues highlight serious deficiencies in quality control and data integrity.
ID · 13248e54-e3eb-4a32-a851-5714545af81e